ModelEdge
Scinai Immunotherapeutics Ltd
SCNI
Filing type
20-F
Filing date
May 12, 2021
Updated
May 13, 2021 ยท 11:19 AM

Filing

20-FAnnual and Transition Report of Foreign Private Issuers

Exhibits

EX-1.1ARTICLES OF ASSOCIATION OF BIONDVAX PHARMACEUTICALS LTDEX-2.3DESCRIPTION OF SHARE CAPITALEX-4.3REMUNERATION POLICYEX-4.16AMENDMENT NO. 1 DATED JANUARY 11, 2021 TO FINANCE CONTRACT DATED JUNE 19, 2017, BY AND BETWEEN BIONDVAX PHARMACEUTICALS LTD. AND THE EUROPEAN INVESTMENT BANKEX-12.1CERTIFICATIONEX-12.2CERTIFICATIONEX-13.1CERTIFICATIONEX-13.2CERTIFICATIONGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicEX-101.INSXBRL INSTANCE FILE